Analyst: Increasing inflation will have multimillion-dollar impact on Novo Nordisk
Increasing cost pressure will slice 10 percent off Novo Nordisk’s profit in 2023, says analyst institution Intron Health.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
Novo Nordisk will take a blow from rising energy costs and an increasing cost pressure due to inflation, according to an analysis from UK-based global healthcare equity research firm Intron heath, which Danish business daily Børsen has seen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
